In addition to lowering cholesterol levels, statins have pleiotropic effects, particularly anti-
inflammatory, antiangiogenic, and antifibrotic, that may be beneficial in some chronic …

In the recent years, there have been an increasing number of reports on favourable effects of
statins in patients with advanced chronic liver disease. These include reduction in portal …

Background Statins have beneficial effects on intrahepatic circulation and decrease portal
hypertension and rifaximin modulates the gut microbiome and might prevent bacterial …

Strategies to prevent infection and improve outcomes in patients with cirrhosis. HAV,
hepatitis A virus; HBV, hepatitis B virus; COVID-19, novel coronavirus disease 2019; NSBB …

Patients with decompensated cirrhosis are currently managed through targeted strategies
aimed at preventing or treating specific complications. In contrast, a disease-modifying agent …

Nonalcoholic fatty liver disease (NAFLD) describes a spectrum of alcohol-like hepatic
histological changes, which occur in the absence of any competing causes of chronic liver …

Background: Patients with cirrhosis and portal hypertension face a high risk of
complications. Besides their anti-inflammatory and antifibrotic effects, statins may reduce …

Statins, the most widely used lipid-lowering drugs, are increasingly recognized to have
pleiotropic effects including anti-inflammatory and antiangiogenic properties as well as …

Background Statin has been more and more widely used in chronic liver disease, however,
existed studies have attained contradictory results. According to the present study, we aimed …

Intercellular crosstalk among various liver cells plays an important role in liver fibrosis,
cirrhosis, and hepatocellular carcinoma (HCC). Capillarization of liver sinusoidal endothelial …